13D/13G Filings - Mereo BioPharma Group plc (MREO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-23
4:18 pm
Unchanged
2022-09-1513DMereo BioPharma Group plc
MREO
Rubric Capital Management LP83,780,600
13.410%
0
(Unchanged)
Filing
History
2022-08-23
6:31 pm
Purchase
2022-08-1913DMereo BioPharma Group plc
MREO
Rubric Capital Management LP83,780,600
14.320%
1,507,790increase
(+1.83%)
Filing
History
2022-06-14
10:21 am
Purchase
2022-06-1313DMereo BioPharma Group plc
MREO
Rubric Capital Management LP82,272,810
14.070%
5,480,185increase
(+7.14%)
Filing
History
2022-06-09
08:00 am
Purchase
2022-06-0913DMereo BioPharma Group plc
MREO
Rubric Capital Management LP76,792,625
13.129%
2,220,390increase
(+2.98%)
Filing
History
2022-05-26
5:29 pm
Purchase
2022-05-2613DMereo BioPharma Group plc
MREO
Rubric Capital Management LP75,000,000
12.820%
75,000,000increase
(New Position)
Filing
History
2022-02-15
12:44 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Rock Springs Capital Management LP5,585,621
5.130%
5,585,621increase
(New Position)
Filing
History
2022-02-14
4:50 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Point72 Asset Management, L.P.10,610,000
9.100%
3,710,331increase
(+53.78%)
Filing
History
2022-02-14
4:40 pm
Sale
2021-12-3113GMereo BioPharma Group plc
MREO
Boxer Capital LLC4,082,576
3.600%
-6,226,674decrease
(-60.40%)
Filing
History
2022-02-14
4:16 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Baker Bros. Advisors LP64,917,601
9.990%
25,285,672increase
(+63.80%)
Filing
History
2022-02-14
08:50 am
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Rubric Capital Management LP74,572,235
13.700%
18,072,235increase
(+31.99%)
Filing
History
2022-02-14
06:19 am
Sale
2021-12-3113GMereo BioPharma Group plc
MREO
Citadel Advisors LLC20,081,572
3.700%
-10,848,814decrease
(-35.07%)
Filing
History
2022-02-11
5:26 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Vivo Capital IX, LLC9,409,051
7.800%
448,755increase
(+5.01%)
Filing
History
2022-02-11
4:37 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Suvretta Capital Management, LLC45,710,335
8.400%
13,882,835increase
(+43.62%)
Filing
History
2022-02-11
4:31 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
ORBIMED ADVISORS LLC6,063,345
5.590%
1,544,989increase
(+34.19%)
Filing
History
2021-12-02
2:31 pm
Purchase
2021-09-3013GMereo BioPharma Group plc
MREO
Rubric Capital Management LP56,500,000
10.380%
56,500,000increase
(New Position)
Filing
History
2021-03-01
5:19 pm
Purchase
2021-02-1713GMereo BioPharma Group plc
MREO
Point72 Asset Management, L.P.6,899,669
6.400%
6,899,669increase
(New Position)
Filing
History
2021-02-19
4:27 pm
Purchase
2021-02-1013GMereo BioPharma Group plc
MREO
Suvretta Capital Management, LLC31,827,500
5.900%
31,827,500increase
(New Position)
Filing
History
2021-02-16
4:53 pm
Purchase
2020-12-3113GMereo BioPharma Group plc
MREO
Baker Bros. Advisors LP39,631,929
11.400%
39,631,929increase
(New Position)
Filing
History
2021-02-16
4:30 pm
Sale
2020-12-3113GMereo BioPharma Group plc
MREO
Vivo Capital IX, LLC8,960,296
8.168%
-21,635,328decrease
(-70.71%)
Filing
History
2021-02-16
4:30 pm
Sale
2020-12-3113GMereo BioPharma Group plc
MREO
Citadel Advisors LLC30,930,386
8.900%
-202,605decrease
(-0.65%)
Filing
History
Goto Prev, 0, 1, 2, 3, Next